Realising the full potential of MR-PHeWAS in cancer. (2021)

First Author: Bowden J
Attributed to:  Pleiotropy robust Mendelian randomization funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-01165-0

PubMed Identifier: 33235313

Publication URI: http://europepmc.org/abstract/MED/33235313

Type: Journal Article/Review

Volume: 124

Parent Publication: British journal of cancer

Issue: 3

ISSN: 0007-0920